Literature DB >> 20841556

Skeletal status in psychotic disorders: a population-based study.

Krista Partti1, Markku Heliövaara, Olli Impivaara, Jonna Perälä, Samuli I Saarni, Jouko Lönnqvist, Jaana M Suvisaari.   

Abstract

OBJECTIVE: To compare the skeletal status of subjects with primary psychotic disorders with the general population by means of bone ultrasound measurements. Schizophrenia seems to be associated with low bone mineral density through a still unclear mechanism, although information on other psychotic disorders is scarce.
METHODS: In a nationally representative sample, quantitative ultrasound values of the heel, i.e., broadband ultrasound attenuation (BUA) and speed of sound, were measured from subjects with schizophrenia (n = 48), other nonaffective psychosis (n = 56), affective psychosis (n = 37), and from 6,100 population controls. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision lifetime psychosis diagnoses were based both on Structured Clinical Interview and case note data. Information on the most common risk factors for bone fragility was elicited through an interview, health examination, and questionnaires. In addition, serum 25-hydroxyvitamin D was measured.
RESULTS: Women with schizophrenia and men with affective psychosis had significantly lower bone ultrasound values as compared with the age- and sex-matched population controls (Z-BUA = -0.54, p = .001 and Z-BUA = -0.37, p = .04, respectively). Significantly lower vitamin D levels were observed in subjects with schizophrenia in comparison with the general population (p = .006). Schizophrenia remained an independent determinant of poor skeletal status in women even after controlling for common risk factors for osteoporosis, vitamin D status, and antipsychotic and mood-stabilizing medication (Z-BUA = -0.54, p = .002).
CONCLUSIONS: In this population-based study, schizophrenia was found to be independently associated with poor skeletal status in women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841556     DOI: 10.1097/PSY.0b013e3181f7abd3

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  14 in total

Review 1.  Osteoporosis and fracture risk in people with schizophrenia.

Authors:  Taishiro Kishimoto; Marc De Hert; Harold E Carlson; Peter Manu; Christoph U Correll
Journal:  Curr Opin Psychiatry       Date:  2012-09       Impact factor: 4.741

2.  Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.

Authors:  James D Clelland; Laura L Read; Valérie Drouet; Angela Kaon; Alexandra Kelly; Karen E Duff; Robert H Nadrich; Amit Rajparia; Catherine L Clelland
Journal:  Schizophr Res       Date:  2014-04-29       Impact factor: 4.939

Review 3.  Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications.

Authors:  Matthieu P K Crews; Oliver D Howes
Journal:  Hum Psychopharmacol       Date:  2012-01-09       Impact factor: 1.672

4.  The association of 25-hydroxyvitamin D3 and D2 with behavioural problems in childhood.

Authors:  Anna-Maija Tolppanen; Adrian Sayers; William D Fraser; Glyn Lewis; Stanley Zammit; Debbie A Lawlor
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

5.  Vitamin D: An overview of vitamin D status and intake in Europe.

Authors:  A Spiro; J L Buttriss
Journal:  Nutr Bull       Date:  2014-12

6.  Dental conditions in inpatients with schizophrenia: a large-scale multi-site survey.

Authors:  Hideaki Tani; Hiroyuki Uchida; Takefumi Suzuki; Yumi Shibuya; Hiroshi Shimanuki; Koichiro Watanabe; Ryosuke Den; Masahiko Nishimoto; Jinichi Hirano; Hiroyoshi Takeuchi; Shintaro Nio; Shinichiro Nakajima; Ryosuke Kitahata; Takashi Tsuboi; Kenichi Tsunoda; Toshiaki Kikuchi; Masaru Mimura
Journal:  BMC Oral Health       Date:  2012-08-18       Impact factor: 2.757

7.  Bone Mineral Density as a Marker of Cumulative Estrogen Exposure in Psychotic Disorder: A 3 Year Follow-Up Study.

Authors:  Christine van der Leeuw; Sanne Peeters; Patrick Domen; Marinus van Kroonenburgh; Jim van Os; Machteld Marcelis
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

8.  A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population.

Authors:  Kevin Williamson; Karen Kilner; Nicola Clibbens
Journal:  J Nutr Sci       Date:  2015-08-20

9.  Chronic Psychosocial Stress Impairs Bone Homeostasis: A Study in the Social Isolation Reared Rat.

Authors:  Stefania Schiavone; Maria G Morgese; Emanuela Mhillaj; Maria Bove; Angelo De Giorgi; Francesco P Cantatore; Claudia Camerino; Paolo Tucci; Nicola Maffulli; Vincenzo Cuomo; Luigia Trabace
Journal:  Front Pharmacol       Date:  2016-06-08       Impact factor: 5.810

10.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.